Literature DB >> 6603848

Pain in the rheumatic diseases. Investigation of a key health status component.

L E Kazis, R F Meenan, J J Anderson.   

Abstract

The importance of pain in the health status and health behavior of patients with chronic rheumatic disease was evaluated. The Arthritis Impact Measurement Scales were used to estimate physical disability, psychological status, and pain in a large set of rheumatic disease patients. Explanatory regression models were built to explore the contribution of pain in physician and patient assessments of overall health, medication usage, and changes in health status over time. Results confirm that pain makes a highly significant contribution to explaining both physician and patient overall health assessments (P less than 0.001). Pain is also the most important of the 3 health status components in explaining medication usage (P less than 0.001). Finally, using prospective data, it is shown that current pain, rather than current physical or psychological disability, is the best predictor of subsequent pain (P less than 0.001). Current pain also is most associated with subsequent physical disability (P less than 0.05). These findings confirm the importance of pain in determining the health status and health behavior of individuals with chronic rheumatic disease, and suggest that doctors and other health professionals should continue to solicit and address the patient's complaints of pain.

Entities:  

Mesh:

Year:  1983        PMID: 6603848     DOI: 10.1002/art.1780260811

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  21 in total

1.  U.S. Physician Recommendations to Their Patients About the Use of Complementary Health Approaches.

Authors:  Barbara J Stussman; Richard R Nahin; Patricia M Barnes; Brian W Ward
Journal:  J Altern Complement Med       Date:  2019-12-02       Impact factor: 2.579

2.  The public neglect of rheumatic diseases: insights from analyses of attendees in a musculoskeletal disease awareness activity.

Authors:  Klaus P Machold; Marcus D Köller; Stephan Pflugbeil; Christof Zimmermann; Ernst Wagner; Ulrike Stuby; Daniel Aletaha; Tanja A Stamm; Franz Mayrhofer; Attila Dunky; Josef Hermann; Wilfried Ilias; Josef S Smolen
Journal:  Ann Rheum Dis       Date:  2007-01-04       Impact factor: 19.103

3.  Energy recovery in individuals with knee osteoarthritis.

Authors:  T L Sparling; D Schmitt; C E Miller; F Guilak; T J Somers; F J Keefe; R M Queen
Journal:  Osteoarthritis Cartilage       Date:  2014-04-18       Impact factor: 6.576

Review 4.  The underestimated long term medical and economic consequences of rheumatoid arthritis.

Authors:  T Pincus
Journal:  Drugs       Date:  1995       Impact factor: 9.546

5.  Biofeedback as a means to alter electromyographic activity in a total knee replacement patient.

Authors:  J C Beckham; F J Keefe; D S Caldwell; C J Brown
Journal:  Biofeedback Self Regul       Date:  1991-03

6.  Reduced cortical responses to noxious heat in patients with rheumatoid arthritis.

Authors:  A K Jones; S W Derbyshire
Journal:  Ann Rheum Dis       Date:  1997-10       Impact factor: 19.103

7.  Evaluating the consequences of rheumatoid arthritis.

Authors:  Björn Sossong; Stefan Felder; Malte Wolff; Klaus Krüger
Journal:  Eur J Health Econ       Date:  2016-07-28

8.  Pain catastrophizing and pain-related fear in osteoarthritis patients: relationships to pain and disability.

Authors:  Tamara J Somers; Francis J Keefe; Jennifer J Pells; Kim E Dixon; Sandra J Waters; Paul A Riordan; James A Blumenthal; Daphne C McKee; Lara LaCaille; Jessica M Tucker; Daniel Schmitt; David S Caldwell; Virginia B Kraus; Ershela L Sims; Rebecca A Shelby; John R Rice
Journal:  J Pain Symptom Manage       Date:  2008-11-28       Impact factor: 3.612

9.  Decreased immunoreactive beta-endorphin in mononuclear leucocytes from patients with rheumatic diseases.

Authors:  C J Wiedermann; P Sacerdote; E Mur; U Kinigadner; T Wicker; A E Panerai; H Braunsteiner
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

10.  Disease severity in rheumatoid arthritis: relationships of plasma tumor necrosis factor-alpha, soluble interleukin 2-receptor, soluble CD4/CD8 ratio, neopterin, and fibrin D-dimer to traditional severity and functional measures.

Authors:  J C Beckham; D S Caldwell; B L Peterson; A M Pippen; M S Currie; F J Keefe; J B Weinberg
Journal:  J Clin Immunol       Date:  1992-09       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.